DiaMedica Therapeutics Inc.

NASDAQ: DMAC
Share price (1/3/25): $5.56
Market cap (1/3/25): $238 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Shelf registration

Exempt offering of securities

Registration of securities for employees

Shelf registration

Ownership Filter

Parsons James T.

Giuffre Randall Michael

Pilnik Richard D.

Semba Charles Pauling

News Filter

Provides a Business Update and Announces Third Quarter 2024 Financial Results

Provides a Business Update and Announces Second Quarter 2024 Financial Results

Announces $11.8 Million Private Placement

Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC